TreeWAS – Variant ID: rs8082590

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C67.9 Bladder, unspecified	0.168	0.832	0.000
C67 Malignant neoplasm of bladder	0.159	0.841	0.000
C67.4 Posterior wall of bladder	0.149	0.851	0.000
C67.6 Ureteric orifice	0.145	0.855	0.000
C67.2 Lateral wall of bladder	0.133	0.867	0.000
C67.3 Anterior wall of bladder	0.125	0.875	0.000
C67.1 Dome of bladder	0.120	0.880	0.000
C67.7 Urachus	0.114	0.886	0.000
C67.8 Overlapping lesion of bladder	0.110	0.890	0.000
C67.0 Trigone of bladder	0.108	0.892	0.000
C67.5 Bladder neck	0.085	0.915	0.000
N42.8 Other specified disorders of prostate	0.040	0.960	0.000
F03 Unspecified dementia	0.036	0.964	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.967	0.033
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.968	0.032
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.968	0.032
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.969	0.031
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.969	0.031
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.969	0.031
T40.2 Other opioids	0.000	0.970	0.030
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.970	0.030
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.970	0.030
T42.4 Benzodiazepines	0.000	0.971	0.029
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.972	0.028
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.973	0.027
T42.1 Iminostilbenes	0.000	0.974	0.026
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.974	0.026
T40.4 Other synthetic narcotics	0.000	0.974	0.026
T43.9 Psychotropic drug, unspecified	0.000	0.974	0.025
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.975	0.025
T40.1 Heroin	0.000	0.975	0.025
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.975	0.025
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.975	0.025
T40.3 Methadone	0.000	0.976	0.024
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.976	0.024
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.976	0.024
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.976	0.024
T39.1 4-Aminophenol derivatives	0.000	0.977	0.023
T40.5 Cocaine	0.000	0.977	0.023
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.977	0.023
T42.0 Hydantoin derivatives	0.000	0.977	0.023
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.977	0.023
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.977	0.023
T40.8 Lysergide [LSD]	0.000	0.977	0.023
T40.7 Cannabis (derivatives)	0.000	0.977	0.023
T40.0 Opium	0.000	0.977	0.023
T42.3 Barbiturates	0.000	0.977	0.023
T39.4 Antirheumatics, not elsewhere classified	0.000	0.977	0.023
T39.2 Pyrazolone derivatives	0.000	0.977	0.023
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.977	0.023
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.977	0.022
T42.2 Succinimides and oxazolidinediones	0.000	0.977	0.022
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.977	0.023
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.977	0.023
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.977	0.023
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.977	0.022
T43.6 Psychostimulants with abuse potential	0.000	0.979	0.021
T40.6 Other and unspecified narcotics	0.000	0.980	0.020
T47.2 Stimulant laxatives	0.000	0.980	0.020
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.980	0.020
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.980	0.019
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.981	0.019
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.981	0.019
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.018	0.982	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.982	0.018
T37.5 Antiviral drugs	0.000	0.982	0.018
T37.4 Anthelminthics	0.000	0.982	0.018
T37.3 Other antiprotozoal drugs	0.000	0.982	0.018
T37.1 Antimycobacterial drugs	0.000	0.982	0.018
T37.0 Sulphonamides	0.000	0.982	0.018
T47.6 Antidiarrhoeal drugs	0.000	0.982	0.018
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.982	0.017
M48.5 Collapsed vertebra, not elsewhere classified	0.018	0.982	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.982	0.017
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.983	0.017
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.983	0.017
T47.7 Emetics	0.000	0.983	0.017
T47.5 Digestants	0.000	0.983	0.017
T47.3 Saline and osmotic laxatives	0.000	0.983	0.017
T43.2 Other and unspecified antidepressants	0.000	0.983	0.017
T47.0 Histamine H(2)-receptor antagonists	0.000	0.983	0.017
T47.4 Other laxatives	0.000	0.983	0.017
M48.02 Spinal stenosis (Cervical region)	0.017	0.983	0.000
T41.5 Therapeutic gases	0.000	0.983	0.017
T41.4 Anaesthetic, unspecified	0.000	0.983	0.017
T41.3 Local anaesthetics	0.000	0.983	0.017
T41.2 Other and unspecified general anaesthetics	0.000	0.983	0.017
T41.1 Intravenous anaesthetics	0.000	0.983	0.017
T41.0 Inhaled anaesthetics	0.000	0.983	0.017
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.983	0.017
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.983	0.017
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.983	0.017
T49.9 Topical agent, unspecified	0.000	0.983	0.017
T49.8 Other topical agents	0.000	0.983	0.017
T49.7 Dental drugs, topically applied	0.000	0.983	0.017
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.983	0.017
T49.5 Ophthalmological drugs and preparations	0.000	0.983	0.017
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.983	0.017
T49.3 Emollients, demulcents and protectants	0.000	0.983	0.017
T49.2 Local astringents and local detergents	0.000	0.983	0.017
T49.1 Antipruritics	0.000	0.983	0.017
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.983	0.017
T48.5 Anti-common-cold drugs	0.000	0.983	0.016
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.983	0.016
T38.9 Other and unspecified hormone antagonists	0.000	0.983	0.016
T38.7 Androgens and anabolic congeners	0.000	0.983	0.016
T38.5 Other oestrogens and progestogens	0.000	0.983	0.016
T38.4 Oral contraceptives	0.000	0.983	0.016
T38.2 Antithyroid drugs	0.000	0.983	0.016
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.983	0.016
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.983	0.016
T48.4 Expectorants	0.000	0.983	0.016
T48.3 Antitussives	0.000	0.983	0.016
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.983	0.016
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.983	0.016
T48.0 Oxytocic drugs	0.000	0.983	0.016
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.984	0.016
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.984	0.016
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.984	0.016
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.984	0.016
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.984	0.016
T44.0 Anticholinesterase agents	0.000	0.984	0.016
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.984	0.016
T46.7 Peripheral vasodilators	0.000	0.984	0.016
M48.0 Spinal stenosis	0.016	0.984	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.984	0.016
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.984	0.016
M48 Other spondylopathies	0.016	0.984	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.984	0.016
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.984	0.016
M48.07 Spinal stenosis (Lumbosacral region)	0.016	0.984	0.000
M20.2 Hallux rigidus	0.016	0.984	0.000
T46.1 Calcium-channel blockers	0.000	0.984	0.016
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.984	0.016
T39.0 Salicylates	0.000	0.984	0.016
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.984	0.015
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.985	0.015
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.015	0.985	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.985	0.015
T45.2 Vitamins, not elsewhere classified	0.000	0.985	0.015
T38.1 Thyroid hormones and substitutes	0.000	0.985	0.015
T38.0 Glucocorticoids and synthetic analogues	0.000	0.985	0.015
T36 Poisoning by systemic antibiotics	0.000	0.985	0.014
C64-C68 Malignant neoplasms of urinary tract	0.014	0.986	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.986	0.014
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.986	0.014
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.986	0.014
T45.8 Other primarily systemic and haematological agents	0.000	0.986	0.014
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.986	0.014
T45.6 Fibrinolysis-affecting drugs	0.000	0.986	0.014
T45.4 Iron and its compounds	0.000	0.986	0.014
T45.3 Enzymes, not elsewhere classified	0.000	0.986	0.014
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.013	0.986	0.000
M48.9 Spondylopathy, unspecified	0.013	0.987	0.000
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.013	0.987	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.987	0.013
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.013	0.987	0.000
M48.00 Spinal stenosis (Multiple sites in spine)	0.013	0.987	0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.013	0.987	0.000
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.013	0.987	0.000
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.013	0.987	0.000
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.013	0.987	0.000
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.013	0.987	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.987	0.013
F00-F09 Organic, including symptomatic, mental disorders	0.013	0.987	0.000
M48.8 Other specified spondylopathies	0.013	0.987	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.987	0.012
L53.9 Erythematous condition, unspecified	0.012	0.988	0.000
M48.03 Spinal stenosis (Cervicothoracic region)	0.012	0.988	0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.012	0.988	0.000
M48.04 Spinal stenosis (Thoracic region)	0.012	0.988	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.988	0.012
T50.5 Appetite depressants	0.000	0.988	0.012
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.988	0.012
T50.0 Mineralocorticoids and their antagonists	0.000	0.988	0.012
M48.4 Fatigue fracture of vertebra	0.012	0.988	0.000
M48.3 Traumatic spondylopathy	0.012	0.988	0.000
M48.2 Kissing spine	0.012	0.988	0.000
M48.1 Ankylosing hyperostosis [Forestier]	0.012	0.988	0.000
M48.05 Spinal stenosis (Thoracolumbar region)	0.012	0.988	0.000
T50.8 Diagnostic agents	0.000	0.988	0.012
L53 Other erythematous conditions	0.012	0.988	0.000
T50.1 Loop [high-ceiling] diuretics	0.000	0.989	0.011
L53.8 Other specified erythematous conditions	0.011	0.989	0.000
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.011	0.989	0.000
M48.96 Spondylopathy, unspecified (Lumbar region)	0.011	0.989	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.989	0.010
T36.7 Antifungal antibiotics, systemically used	0.000	0.989	0.010
T36.6 Rifamycins	0.000	0.989	0.010
T36.5 Aminoglycosides	0.000	0.989	0.010
T36.2 Chloramphenicol group	0.000	0.989	0.010
L52 Erythema nodosum	0.011	0.989	0.000
T45.5 Anticoagulants	0.000	0.989	0.010
M48.99 Spondylopathy, unspecified (Site unspecified)	0.010	0.989	0.000
C66 Malignant neoplasm of ureter	0.010	0.990	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.990	0.010
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)	0.010	0.990	0.000
M48.87 Other specified spondylopathies (Lumbosacral region)	0.010	0.990	0.000
L50-L54 Urticaria and erythema	0.010	0.990	0.000
M48.92 Spondylopathy, unspecified (Cervical region)	0.010	0.990	0.000
T36.0 Penicillins	0.000	0.990	0.010
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.010	0.990	0.000
M48.82 Other specified spondylopathies (Cervical region)	0.010	0.990	0.000
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.010	0.990	0.000
M48.97 Spondylopathy, unspecified (Lumbosacral region)	0.010	0.990	0.000
M48.95 Spondylopathy, unspecified (Thoracolumbar region)	0.010	0.990	0.000
M48.94 Spondylopathy, unspecified (Thoracic region)	0.010	0.990	0.000
M48.93 Spondylopathy, unspecified (Cervicothoracic region)	0.010	0.990	0.000
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)	0.010	0.990	0.000
M48.90 Spondylopathy, unspecified (Multiple sites in spine)	0.010	0.990	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.010	0.990	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.990	0.010
T36.3 Macrolides	0.000	0.990	0.009
T36.8 Other systemic antibiotics	0.000	0.990	0.009
F09 Unspecified organic or symptomatic mental disorder	0.009	0.990	0.000
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.009	0.991	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.009	0.991	0.000
M48.89 Other specified spondylopathies (Site unspecified)	0.009	0.991	0.000
M48.85 Other specified spondylopathies (Thoracolumbar region)	0.009	0.991	0.000
M48.84 Other specified spondylopathies (Thoracic region)	0.009	0.991	0.000
M48.83 Other specified spondylopathies (Cervicothoracic region)	0.009	0.991	0.000
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)	0.009	0.991	0.000
M48.80 Other specified spondylopathies (Multiple sites in spine)	0.009	0.991	0.000
T50.4 Drugs affecting uric acid metabolism	0.000	0.991	0.009
F00 Dementia in Alzheimer's disease	0.009	0.991	0.000
F05.9 Delirium, unspecified	0.009	0.991	0.000
L50 Urticaria	0.009	0.991	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.009	0.991	0.000
K25.3 Acute without haemorrhage or perforation	0.009	0.991	0.000
F02 Dementia in other diseases classified elsewhere	0.009	0.991	0.000
F01 Vascular dementia	0.009	0.991	0.000
L50.9 Urticaria, unspecified	0.009	0.991	0.000
T36.4 Tetracyclines	0.001	0.991	0.008
M48.19 Ankylosing hyperostosis [Forestier] (Site unspecified)	0.008	0.991	0.000
M48.18 Ankylosing hyperostosis [Forestier] (Sacral and sacrococcygeal region)	0.008	0.991	0.000
M48.17 Ankylosing hyperostosis [Forestier] (Lumbosacral region)	0.008	0.991	0.000
M48.16 Ankylosing hyperostosis [Forestier] (Lumbar region)	0.008	0.991	0.000
M48.15 Ankylosing hyperostosis [Forestier] (Thoracolumbar region)	0.008	0.991	0.000
M48.14 Ankylosing hyperostosis [Forestier] (Thoracic region)	0.008	0.991	0.000
M48.13 Ankylosing hyperostosis [Forestier] (Cervicothoracic region)	0.008	0.991	0.000
M48.12 Ankylosing hyperostosis [Forestier] (Cervical region)	0.008	0.991	0.000
M48.11 Ankylosing hyperostosis [Forestier] (Occipito-atlanto-axial region)	0.008	0.991	0.000
M48.10 Ankylosing hyperostosis [Forestier] (Multiple sites in spine)	0.008	0.991	0.000
M48.29 Kissing spine (Site unspecified)	0.008	0.991	0.000
M48.28 Kissing spine (Sacral and sacrococcygeal region)	0.008	0.991	0.000
M48.27 Kissing spine (Lumbosacral region)	0.008	0.991	0.000
M48.26 Kissing spine (Lumbar region)	0.008	0.991	0.000
M48.25 Kissing spine (Thoracolumbar region)	0.008	0.991	0.000
M48.24 Kissing spine (Thoracic region)	0.008	0.991	0.000
M48.23 Kissing spine (Cervicothoracic region)	0.008	0.991	0.000
M48.22 Kissing spine (Cervical region)	0.008	0.991	0.000
M48.21 Kissing spine (Occipito-atlanto-axial region)	0.008	0.991	0.000
M48.20 Kissing spine (Multiple sites in spine)	0.008	0.991	0.000
M48.39 Traumatic spondylopathy (Site unspecified)	0.008	0.991	0.000
M48.38 Traumatic spondylopathy (Sacral and sacrococcygeal region)	0.008	0.991	0.000
M48.37 Traumatic spondylopathy (Lumbosacral region)	0.008	0.991	0.000
M48.36 Traumatic spondylopathy (Lumbar region)	0.008	0.991	0.000
M48.35 Traumatic spondylopathy (Thoracolumbar region)	0.008	0.991	0.000
M48.34 Traumatic spondylopathy (Thoracic region)	0.008	0.991	0.000
M48.33 Traumatic spondylopathy (Cervicothoracic region)	0.008	0.991	0.000
M48.32 Traumatic spondylopathy (Cervical region)	0.008	0.991	0.000
M48.31 Traumatic spondylopathy (Occipito-atlanto-axial region)	0.008	0.991	0.000
M48.30 Traumatic spondylopathy (Multiple sites in spine)	0.008	0.991	0.000
M48.49 Fatigue fracture of vertebra (Site unspecified)	0.008	0.991	0.000
M48.48 Fatigue fracture of vertebra (Sacral and sacrococcygeal region)	0.008	0.991	0.000
M48.47 Fatigue fracture of vertebra (Lumbosacral region)	0.008	0.991	0.000
M48.46 Fatigue fracture of vertebra (Lumbar region)	0.008	0.991	0.000
M48.45 Fatigue fracture of vertebra (Thoracolumbar region)	0.008	0.991	0.000
M48.44 Fatigue fracture of vertebra (Thoracic region)	0.008	0.991	0.000
M48.43 Fatigue fracture of vertebra (Cervicothoracic region)	0.008	0.991	0.000
M48.42 Fatigue fracture of vertebra (Cervical region)	0.008	0.991	0.000
M48.41 Fatigue fracture of vertebra (Occipito-atlanto-axial region)	0.008	0.991	0.000
M48.40 Fatigue fracture of vertebra (Multiple sites in spine)	0.008	0.991	0.000
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.009	0.991	0.000
L53.3 Other chronic figurate erythema	0.008	0.991	0.000
L53.2 Erythema marginatum	0.008	0.991	0.000
L53.1 Erythema annulare centrifugum	0.008	0.991	0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.008	0.992	0.000
L53.0 Toxic erythema	0.008	0.992	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.008	0.992	0.000
L50.8 Other urticaria	0.008	0.992	0.000
C65 Malignant neoplasm of renal pelvis	0.007	0.992	0.000
L54 Erythema in diseases classified elsewhere	0.007	0.992	0.000
F07.0 Organic personality disorder	0.007	0.992	0.000
F02.3 Dementia in Parkinson's disease	0.007	0.993	0.000
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.007	0.993	0.000
F07.1 Postencephalitic syndrome	0.007	0.993	0.000
M48.86 Other specified spondylopathies (Lumbar region)	0.007	0.993	0.000
M48.09 Spinal stenosis (Site unspecified)	0.007	0.993	0.000
F01.1 Multi-infarct dementia	0.007	0.993	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.007	0.993	0.000
F05.8 Other delirium	0.007	0.993	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.993	0.007
F07.2 Postconcussional syndrome	0.007	0.993	0.000
L50.6 Contact urticaria	0.007	0.993	0.000
L50.5 Cholinergic urticaria	0.007	0.993	0.000
L50.4 Vibratory urticaria	0.007	0.993	0.000
L50.3 Dermatographic urticaria	0.007	0.993	0.000
L50.2 Urticaria due to cold and heat	0.007	0.993	0.000
F05.1 Delirium superimposed on dementia	0.007	0.993	0.000
C68.8 Overlapping lesion of urinary organs	0.007	0.993	0.000
C68.1 Paraurethral glands	0.007	0.993	0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.007	0.993	0.000
F02.2 Dementia in Huntington's disease	0.007	0.993	0.000
F02.1 Dementia in Creutzfeldt-Jakob disease	0.007	0.993	0.000
F01.8 Other vascular dementia	0.007	0.993	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.007	0.993	0.000
F01.2 Subcortical vascular dementia	0.007	0.993	0.000
F01.0 Vascular dementia of acute onset	0.007	0.993	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.006	0.993	0.000
C68.9 Urinary organ, unspecified	0.006	0.993	0.000
M80.9 Unspecified osteoporosis with pathological fracture	0.007	0.993	0.000
F02.0 Dementia in Pick's disease	0.006	0.994	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.006	0.994	0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.006	0.994	0.000
K25.4 Chronic or unspecified with haemorrhage	0.006	0.994	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.006	0.994	0.000
L51 Erythema multiforme	0.006	0.994	0.000
C68.0 Urethra	0.005	0.994	0.000
Z00.0 General medical examination	0.000	0.994	0.006
F02.8 Dementia in other specified diseases classified elsewhere	0.005	0.994	0.000
L54.8 Erythema in other diseases classified elsewhere	0.005	0.994	0.000
L54.0 Erythema marginatum in acute rheumatic fever	0.005	0.994	0.000
L50.1 Idiopathic urticaria	0.005	0.994	0.000
L50.0 Allergic urticaria	0.006	0.994	0.000
F01.9 Vascular dementia, unspecified	0.006	0.994	0.000
F05.0 Delirium not superimposed on dementia, so described	0.005	0.994	0.000
K25 Gastric ulcer	0.006	0.994	0.000
Z00 General examination and investigation of persons without complaint or reported diagnosis	0.000	0.995	0.005
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.005	0.995	0.000
Z00.8 Other general examinations	0.000	0.995	0.005
F06.7 Mild cognitive disorder	0.005	0.995	0.000
F06.6 Organic emotionally labile [asthenic] disorder	0.005	0.995	0.000
F06.5 Organic dissociative disorder	0.005	0.995	0.000
F06.4 Organic anxiety disorder	0.005	0.995	0.000
F06.1 Organic catatonic disorder	0.005	0.995	0.000
F06.0 Organic hallucinosis	0.005	0.995	0.000
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.005	0.995	0.000
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.005	0.995	0.000
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.005	0.995	0.000
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.005	0.995	0.000
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.005	0.995	0.000
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.005	0.995	0.000
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.005	0.995	0.000
O63.9 Long labour, unspecified	0.000	0.995	0.005
D35.1 Parathyroid gland	0.005	0.995	0.000
Z00.6 Examination for normal comparison and control in clinical research programme	0.000	0.995	0.005
M20.6 Acquired deformity of toe(s), unspecified	0.005	0.995	0.000
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.005	0.995	0.000
C71 Malignant neoplasm of brain	0.005	0.995	0.000
Z00.4 General psychiatric examination, not elsewhere classified	0.000	0.995	0.005
K25.6 Chronic or unspecified with both haemorrhage and perforation	0.004	0.995	0.000
L51.8 Other erythema multiforme	0.004	0.995	0.000
L51.2 Toxic epidermal necrolysis [Lyell]	0.004	0.995	0.000
L51.0 Nonbullous erythema multiforme	0.004	0.995	0.000
M54.39 Sciatica (Site unspecified)	0.000	0.995	0.005
C71.3 Parietal lobe	0.004	0.996	0.000
J31.0 Chronic rhinitis	0.004	0.996	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.004	0.996	0.000
F06.3 Organic mood [affective] disorders	0.004	0.996	0.000
M20 Acquired deformities of fingers and toes	0.004	0.996	0.000
K25.5 Chronic or unspecified with perforation	0.004	0.996	0.000
N28.1 Cyst of kidney, acquired	0.004	0.996	0.000
K25.1 Acute with perforation	0.004	0.996	0.000
Z00.5 Examination of potential donor of organ and tissue	0.000	0.996	0.004
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.004	0.996	0.000
L51.1 Bullous erythema multiforme	0.004	0.996	0.000
C71.9 Brain, unspecified	0.004	0.996	0.000
K25.2 Acute with both haemorrhage and perforation	0.004	0.996	0.000
C71.0 Cerebrum, except lobes and ventricles	0.004	0.996	0.000
M20.1 Hallux valgus (acquired)	0.004	0.996	0.000
R73.0 Abnormal glucose tolerance test	0.000	0.996	0.004
Z00.3 Examination for adolescent development state	0.000	0.996	0.004
Z00.2 Examination for period of rapid growth in childhood	0.000	0.996	0.004
Z00.1 Routine child health examination	0.000	0.996	0.004
G95.8 Other specified diseases of spinal cord	0.004	0.996	0.000
N42 Other disorders of prostate	0.004	0.996	0.000
C71.2 Temporal lobe	0.004	0.996	0.000
C71.1 Frontal lobe	0.004	0.996	0.000
C71.7 Brain stem	0.004	0.996	0.000
C71.6 Cerebellum	0.004	0.996	0.000
C71.5 Cerebral ventricle	0.004	0.996	0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.003	0.996	0.000
T17.9 Foreign body in respiratory tract, part unspecified	0.004	0.996	0.000
M20.0 Deformity of finger(s)	0.004	0.996	0.000
C71.4 Occipital lobe	0.004	0.996	0.000
K25.0 Acute with haemorrhage	0.004	0.996	0.000
Q23.1 Congenital insufficiency of aortic valve	0.004	0.996	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.997	0.003
Q28.2 Arteriovenous malformation of cerebral vessels	0.003	0.997	0.000
M85.80 Other specified disorders of bone density and structure (Multiple sites)	0.003	0.997	0.000
L51.9 Erythema multiforme, unspecified	0.003	0.997	0.000
N42.0 Calculus of prostate	0.003	0.997	0.000
Q23 Congenital malformations of aortic and mitral valves	0.003	0.997	0.000
Z89.5 Acquired absence of leg at or below knee	0.000	0.997	0.003
Q28 Other congenital malformations of circulatory system	0.003	0.997	0.000
M50.0 Cervical disk disorder with myelopathy	0.003	0.997	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.003	0.997	0.000
C71.8 Overlapping lesion of brain	0.003	0.997	0.000
J34.3 Hypertrophy of nasal turbinates	0.003	0.997	0.000
Z88.4 Personal history of allergy to anaesthetic agent	0.000	0.997	0.003
B37.0 Candidal stomatitis	0.000	0.997	0.003
M80 Osteoporosis with pathological fracture	0.003	0.997	0.000
Q53.1 Undescended testicle, unilateral	0.003	0.997	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.003	0.997	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.003	0.997	0.000
N42.3 Dysplasia of prostate	0.003	0.997	0.000
Q23.0 Congenital stenosis of aortic valve	0.003	0.997	0.000
C69 Malignant neoplasm of eye and adnexa	0.003	0.997	0.000
K04.8 Radicular cyst	0.003	0.997	0.000
B49 Unspecified mycosis	0.000	0.997	0.003
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.997	0.003
A49.9 Bacterial infection, unspecified	0.000	0.997	0.003
C69.6 Orbit	0.003	0.997	0.000
K04.9 Other and unspecified diseases of pulp and periapical tissues	0.003	0.997	0.000
S56.4 Injury of extensor muscle and tendon of other finger(s) at forearm level	0.003	0.997	0.000
C69.9 Eye, unspecified	0.003	0.997	0.000
Q25 Congenital malformations of great arteries	0.003	0.997	0.000
Q23.3 Congenital mitral insufficiency	0.003	0.997	0.000
T17 Foreign body in respiratory tract	0.003	0.997	0.000
Q25.4 Other congenital malformations of aorta	0.003	0.997	0.000
M80.0 Postmenopausal osteoporosis with pathological fracture	0.003	0.997	0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.003	0.997	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.003	0.997	0.000
Q23.4 Hypoplastic left heart syndrome	0.003	0.997	0.000
Q23.2 Congenital mitral stenosis	0.003	0.997	0.000
E55.9 Vitamin D deficiency, unspecified	0.000	0.997	0.003
Q28.9 Congenital malformation of circulatory system, unspecified	0.003	0.997	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.003	0.997	0.000
Q28.1 Other malformations of precerebral vessels	0.003	0.997	0.000
Q27 Other congenital malformations of peripheral vascular system	0.003	0.997	0.000
Q28.3 Other malformations of cerebral vessels	0.003	0.997	0.000
H54.4 Blindness, one eye	0.003	0.997	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.003	0.997	0.000
M85.8 Other specified disorders of bone density and structure	0.003	0.997	0.000
Q53 Undescended testicle	0.003	0.997	0.000
S56 Injury of muscle and tendon at forearm level	0.003	0.997	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.997	0.003
Q38.7 Pharyngeal pouch	0.003	0.997	0.000
G95 Other diseases of spinal cord	0.003	0.997	0.000
C79.2 Secondary malignant neoplasm of skin	0.003	0.997	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.002	0.997	0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.002	0.997	0.000
G95.1 Vascular myelopathies	0.002	0.997	0.000
N34.3 Urethral syndrome, unspecified	0.000	0.997	0.002
N80.9 Endometriosis, unspecified	0.003	0.997	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.000	0.998	0.002
Q25.6 Stenosis of pulmonary artery	0.002	0.998	0.000
T17.5 Foreign body in bronchus	0.002	0.998	0.000
M80.4 Drug-induced osteoporosis with pathological fracture	0.002	0.998	0.000
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture	0.002	0.998	0.000
M80.2 Osteoporosis of disuse with pathological fracture	0.002	0.998	0.000
R22.3 Localised swelling, mass and lump, upper limb	0.002	0.998	0.000
C70 Malignant neoplasm of meninges	0.002	0.998	0.000
T17.3 Foreign body in larynx	0.002	0.998	0.000
T23.0 Burn of unspecified degree of wrist and hand	0.000	0.998	0.002
Q20 Congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
S56.3 Injury of extensor or abductor muscles and tendons of thumb at forearm level	0.002	0.998	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.002	0.998	0.000
Q26 Congenital malformations of great veins	0.002	0.998	0.000
M85.82 Other specified disorders of bone density and structure (Upper arm)	0.002	0.998	0.000
C69.8 Overlapping lesion of eye and adnexa	0.002	0.998	0.000
C69.5 Lachrymal gland and duct	0.002	0.998	0.000
C69.2 Retina	0.002	0.998	0.000
C69.1 Cornea	0.002	0.998	0.000
N42.2 Atrophy of prostate	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.000	0.998	0.002
C69.0 Conjunctiva	0.002	0.998	0.000
N80.1 Endometriosis of ovary	0.002	0.998	0.000
S56.1 Injury of flexor muscle and tendon of other finger(s) at forearm level	0.002	0.998	0.000
H35.6 Retinal haemorrhage	0.000	0.998	0.002
Q53.2 Undescended testicle, bilateral	0.002	0.998	0.000
S56.8 Injury of other and unspecified muscles and tendons at forearm level	0.002	0.998	0.000
M80.8 Other osteoporosis with pathological fracture	0.002	0.998	0.000
G95.0 Syringomyelia and syringobulbia	0.002	0.998	0.000
Q25.9 Congenital malformation of great arteries, unspecified	0.002	0.998	0.000
Q25.8 Other congenital malformations of great arteries	0.002	0.998	0.000
Q25.5 Atresia of pulmonary artery	0.002	0.998	0.000
Q25.2 Atresia of aorta	0.002	0.998	0.000
Q87.4 Marfan's syndrome	0.002	0.998	0.000
T17.4 Foreign body in trachea	0.002	0.998	0.000
T17.1 Foreign body in nostril	0.002	0.998	0.000
T17.0 Foreign body in nasal sinus	0.002	0.998	0.000
I69 Sequelae of cerebrovascular disease	0.000	0.998	0.002
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)	0.002	0.998	0.000
A49.1 Streptococcal infection, unspecified	0.000	0.998	0.002
B37.3 Candidiasis of vulva and vagina	0.000	0.998	0.002
Q53.9 Undescended testicle, unspecified	0.002	0.998	0.000
M80.09 Postmenopausal osteoporosis with pathological fracture (Site unspecified)	0.002	0.998	0.000
M80.08 Postmenopausal osteoporosis with pathological fracture (Other)	0.002	0.998	0.000
M80.07 Postmenopausal osteoporosis with pathological fracture (Ankle and foot)	0.002	0.998	0.000
M80.06 Postmenopausal osteoporosis with pathological fracture (Lower leg)	0.002	0.998	0.000
M80.05 Postmenopausal osteoporosis with pathological fracture (Pelvic region and thigh)	0.002	0.998	0.000
M80.04 Postmenopausal osteoporosis with pathological fracture (Hand)	0.002	0.998	0.000
M80.03 Postmenopausal osteoporosis with pathological fracture (Forearm)	0.002	0.998	0.000
M80.02 Postmenopausal osteoporosis with pathological fracture (Upper arm)	0.002	0.998	0.000
M80.01 Postmenopausal osteoporosis with pathological fracture (Shoulder region)	0.002	0.998	0.000
L60.9 Nail disorder, unspecified	0.002	0.998	0.000
M80.5 Idiopathic osteoporosis with pathological fracture	0.002	0.998	0.000
Q27.1 Congenital renal artery stenosis	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations